Compare TBI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBI | PROF |
|---|---|---|
| Founded | 1985 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.5M | 243.2M |
| IPO Year | 1995 | 2017 |
| Metric | TBI | PROF |
|---|---|---|
| Price | $6.63 | $6.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 300.4K | 63.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.39 | 25.89 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | $6.25 | $92.40 |
| Revenue Next Year | $3.90 | $64.10 |
| P/E Ratio | ★ N/A | $35.74 |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $3.18 | $3.92 |
| 52 Week High | $7.78 | $8.95 |
| Indicator | TBI | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 46.15 |
| Support Level | $5.44 | $6.54 |
| Resistance Level | $6.61 | $7.07 |
| Average True Range (ATR) | 0.40 | 0.29 |
| MACD | 0.05 | -0.05 |
| Stochastic Oscillator | 71.96 | 35.67 |
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.